Hyloris Pharmaceuticals SA (HYL)
EU
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current HYL market cap is 151.2M. The company's latest EPS is EUR -0.5493 and P/E is -9.83.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 91k | 175k | 3.1M | 2.39M | 4.21M |
| Operating Income | -5.27M | -7.05M | -10.54M | -11.64M | -15.99M |
| Net Income | -5.37M | -7.15M | -11.58M | -11.91M | -15.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 5.98M | 69.18M | 63.44M | 60.73M | 47.68M |
| Total Liabilities | 16.17M | 10.12M | 15.39M | 6.82M | 8.61M |
| Total Equity | -10.19M | 59.06M | 48.06M | 53.91M | 39.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -4.56M | -4.57M | -11.25M | -13.02M | -12.81M |
| Investing | -1.23M | -633k | -3.08M | -11.37M | 9.89M |
| Financing | 3.31M | 69.4M | -62k | 7.84M | -131k |
| Market Cap | 151.2M |
| Price to Earnings Ratio | -9.83 |
| Price to Sales Ratio | 35.88 |
| Price to Cash Ratio | 4.97 |
| Price to Book Ratio | 3.87 |
| Dividend Yield | - |
| Shares Outstanding | 28M |
| Average Volume (1 week) | 4.17k |
| Average Volume (1 Month) | 3.36k |
| 52 Week Change | -57.81% |
| 52 Week High | 13.30 |
| 52 Week Low | 2.89 |
| Spread (Intraday) | 0.12 (2.21%) |
| Company Name | Hyloris Pharmaceuticals SA |
| Address |
boulevard patience et beaujonc liege, liege 4000 |
| Website | https://www.hyloris.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
